LSHTM partners with Johnson & Johnson

The London School of Hygiene & Tropical Medicine (LSHTM) has entered into a new partnership with the company Johnson & Johnson to join forces in the combat against antimicrobial resistance and tuberculosis. The collaboration builds on Johnson & Johnson’s decades-long research on multidrug-resistant TB and its strong relationship with LSHTM, which includes the development of the Johnson & Johnson Ebola vaccine regimen.

The novel, inaugural J&J Center for Global Health Discovery (J&J CGHD) will be hosted at LSHTM and forms part of an innovative network of several Johnson & Johnson partnerships with academia, aimed at speeding up research and innovation to fight most urgent global health menaces. The public-private partnership of the J&J CGHD will push forward the deciding, early-stage discovery and exploratory research which is required to be able to come up with innovations that have the potential to save lives. Professor Peter Piot, Director of the London School of Hygiene & Tropical Medicine, said: “The response to the COVID-19 pandemic has powerfully demonstrated the importance of investing in basic science and discovery. We have long worked with Johnson & Johnson to tackle significant global health challenges, like tuberculosis and Ebola, and are eager to build on this work in pursuit of a healthier, safer and more equitable world.”